The long-awaited alternative to Coumadin (warfarin) has just been approved by the US FDA. The FDA just approved Pradaxa (dabigatran) for use by those with atrial fibrillation for preventing afib-related strokes. The FDA based approval on results of the RE-LY trial, which saw patients on Pradaxa having fewer strokes than those on warfarin. And Pradaxa [...]
Breaking News: FDA Panel Unanimously Recommends Approval of Dabigatran to Decrease Stroke Risk in Atrial Fibrillation
An FDA panel today unanimously recommended that the FDA approve dabigatran (Pradaxa) for reducing the risk of afib strokes. FDA approval is expected quickly, making this the first alternative to warfarin approved in the United States, and also the first atrial fibrillation approval for dabigatran. It is approved in over 70 countries for venous thromboembolisms [...]
@stopafib to live-tweet from FDA hearing on Dabigatran to replace warfarin for afib
Next Monday, September 20, 2010, StopAfib.org will be covering the FDA’s hearing on dabigatran (Pradaxa), the new alternative to warfarin, and will be “live-tweeting” from the hearing. Get first reports as they happen by following @stopafib on Twitter. If you’re already on Twitter, just follow us from the toolbar at the bottom of this page. [...]
Dabigatran Beats Warfarin for Stroke Prevention in Atrial Fibrillation
There is a lot of big news coming out of the European Society of Cardiology (ESC) going on in Barcelona right now. Judging by attendance, this is probably the biggest cardiology event in the world. The big announcement for atrial fibrillation sufferers is the progress towards a replacement for Coumadin (warfarin) coming out of the [...]
Atrial Fibrillation & Coumadin® Replacements–StopAfib.org interviews Dr. Manish Shah
Dr. Manish Shah talks about Dabigatran and Rivaroxaban, new drugs in clinicals trials to replace the blood thinner Coumadin® (warfarin), an anticoagulant frequently used to avoid strokes by those with atrial fibrillation. He talks about the two categories of these new drugs, thrombin inhibitors and Factor Xa (10a) inhibitors. Dr.
Video: Dabigatran and Rivaroxaban are possible Coumadin replacements
If you’re on Coumadin or warfarin for your atrial fibrillation, you’re probably interested in the coming replacements for it. In part 2 of our Coumadin series, Dr. Manish Shah, Electrophysiologist at Washington Hospital Center in Washington, DC, talks about the clotting cascade and two drugs that are potential replacements for Coumadin. See the video at: [...]
